Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
Peter J. Goadsby, David W. Dodick, Jessica Ailani, Joel M. Trugman, Michelle Finnegan, Kaifeng Lu, Armin Szegedi
Topics & Concepts
TolerabilityMigraineMedicineAdverse effectPlaceboClinical trialRandomized controlled trialInternal medicineAlternative medicinePathologyMigraine and Headache StudiesTraumatic Brain Injury and Neurovascular DisturbancesNeurological Disorders and Treatments